Influenza virus infection and vaccination in Guillain-Barré syndrome and Multiple Sclerosis
Has parts
Paper I: Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PloS ONE. 2014;9(1):e82222. The article is available in the main thesis. The article is also available at: https://dx.doi.org/10.1371/journal.pone.0082222Paper II: Olberg HK, Cox RJ, Nostbakken JK, Aarseth JH, Vedeler CA, Myhr KM. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Multiple Sclerosis Journal. 2014 Jul;20(8):1074-80. The article is not available in BORA due to publisher restrictions. The published version is available at: https://doi.org/10.1177/1352458513513970
Paper III: Olberg HK, Eide GE, Cox RJ, Jul‐Larsen Å, Lartey SL, Vedeler CA, Myhr KM. Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. European journal of neurology. 2018 Mar;25(3):527-34. The article is available in the main thesis. The article is also available at: https://doi.org/10.1111/ene.13537